Senior insider sale
Chief Financial Officer at VIKING THERAPEUTICS, INC. — senior position signals high conviction
$710.1K
21.22K shares
What this filing means
ZANTE GREG plans to sell 21.22K shares of VIKING THERAPEUTICS, INC. valued at approximately $710.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/29/2026ACC: 0001950047-26-007380
Officer· Chief Financial Officer
Since Jan 2021
21.22K
Shares to sell
$710.1K
Approx. market value
21.22K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Performance Stock Units
Cash
7/28/2026
21.22KTotal acquired21.22K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/28/2026 | Performance Stock Units Cash | 21.22K | — |
| Total | 21.22K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
21.22K
Market value
$710.1K
7/29/2026
Total
Units
21.22K
Value
$710.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
7/29/2026 | 21.22K | $710.1K | NASDAQ | Planned |
| Total | 21.22K | $710.1K | ||